David Helekal

9PUBLICATIONS
14CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Health and ecological risk assessmentObstetrics and gynaecologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 24, 2026
Bayesian adaptive experimental design for efficient microbial genome-wide association studies.

|Aug 20, 2026
The Impact of Doxycycline Post-Exposure Prophylaxis on Antibiotic Use at a Boston Sexual Health Clinic.

|May 18, 2026
Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae.

|Mar 20, 2026
Genetic Background Modulates Zoliflodacin and Gepotidacin Cross-Resistance and Fitness in Neisseria gonorrhoeae.

Aditi Mukherjee, Sofia O P Blomqvist, David Helekal

|Jan 08, 2026
Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.

Madeleine C Kline, Kirstin Oliveira Roster, David Helekal

|Dec 15, 2025
Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae.

Aditi Mukherjee, Sofia Op Blomqvist, David Helekal

Pageof 2

Frequent Collaborators

9 joint publications

Yonatan H Grad

5 joint publications

Aditi Mukherjee

5 joint publications

Samantha G Palace

4 joint publications

Sofia Op Blomqvist